YSB Inc. (HKG:9885)
Hong Kong · Delayed Price · Currency is HKD 3.550
+0.225 (6.77%)
Aug 21, 2026, 4:08 PM HKT
YSB Inc. Revenue
YSB Inc. had revenue of 11.13B CNY in the half year ending December 31, 2025, with 23.59% growth. This brings the company's revenue in the last twelve months to 21.41B, up 13.09% year-over-year. In the year 2025, YSB Inc. had annual revenue of 20.97B with 17.13% growth.
Revenue (ttm)
21.41B CNY
Revenue Growth
+13.09%
P/S Ratio
0.10
Revenue / Employee
3.08M CNY
Employees
6,950
Market Cap
2.42B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.97B | 3.07B | 17.13% |
| Dec 31, 2024 | 17.90B | 931.33M | 5.49% |
| Dec 31, 2023 | 16.97B | 2.70B | 18.90% |
| Dec 31, 2022 | 14.27B | 4.18B | 41.43% |
| Dec 31, 2021 | 10.09B | 4.03B | 66.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 91.25B |
| Alibaba Health Information Technology | 38.94B |
| Fangzhou | 3.92B |
| Shanghai Pioneer Holding | 1.43B |
| Tycoon Group Holdings | 1.10B |
| Kingworld Medicines Group | 1.02B |
| Universal Health International Group Holding | 597.78M |
| New Ray Medicine International Holding | 130.37M |